日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma

克隆相关的滤泡性淋巴瘤和组织细胞肉瘤的共存

Haebe, Sarah; Czerwinski, Debra K; Sathe, Anuja; Grimes, Susan M; Chen, Tianqi; Suarez, Carlos J; Martin, Brock; Ji, Hanlee P; Levy, Ronald; Shree, Tanaya

A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies.

一项针对低级别 B 细胞淋巴瘤患者的 I 期临床试验,将 OX40 激动剂添加到原位治疗性癌症疫苗中,凸显了从小鼠研究到人体研究转化过程中面临的挑战

Shree Tanaya, Czerwinski Debra, Haebe Sarah, Sathe Anuja, Grimes Sue, Martin Brock, Ozawa Michael, Hoppe Richard, Ji Hanlee, Levy Ronald

Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients

在NUT癌患者的一线化疗中加入免疫检查点抑制剂

Haebe, Sarah; Schuebbe, Gesa; Jurmeister, Philipp; von Bergwelt-Baildon, Michael; Westphalen, C Benedikt; Lauer, Ulrich M; Kunz, Wolfgang G; Subklewe, Marion; Weigert, Oliver

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation

移植前微小残留病灶似乎不影响NPM1突变型急性髓系白血病患者接受异基因造血干细胞移植后的生存率。

Fraccaroli, Alessia; Jurinovic, Vindi; Hirschbühl, Klaus; Stauffer, Elena; Koch, Katrin; Breitkopf, Stephan; Haebe, Sarah; Drolle, Heidrun; Rothenberg-Thurley, Maja; Dufour, Annika; Metzeler, Klaus H; Spiekermann, Karsten; Hentrich, Marcus; Hausmann, Andreas; Verbeek, Mareike; Schmid, Christoph; Herold, Tobias; Tischer, Johanna

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

一项针对淋巴瘤的治疗性疫苗临床试验,采用连续肿瘤取样和单细胞分析方法。

Shree, Tanaya; Haebe, Sarah; Czerwinski, Debra K; Eckhert, Erik; Day, Grady; Sathe, Anuja; Grimes, Susan; Frank, Matthew J; Maeda, Lauren S; Alizadeh, Ash A; Advani, Ranjana; Hoppe, Richard T; Long, Steven R; Martin, Brock; Ozawa, Michael G; Khodadoust, Michael S; Ji, Hanlee P; Levy, Ronald

Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor

滤泡性淋巴瘤的发生发展依赖于B细胞受体中获得的糖基化基序,但这种依赖性是可以克服的。

Haebe, Sarah; Day, Grady; Czerwinski, Debra K; Sathe, Anuja; Grimes, Susan M; Chen, Tianqi; Long, Steven R; Martin, Brock; Ozawa, Michael G; Ji, Hanlee P; Shree, Tanaya; Levy, Ronald

Serial FNA allows direct sampling of malignant and infiltrating immune cells in patients with B-cell lymphoma receiving immunotherapy

连续细针穿刺活检可直接采集接受免疫治疗的B细胞淋巴瘤患者的恶性细胞和浸润性免疫细胞样本。

Mooney, Kelly L; Czerwinski, Debra K; Shree, Tanaya; Frank, Matthew J; Haebe, Sarah; Martin, Brock A; Testa, Stefano; Levy, Ronald; Long, Steven R

Intratumoral Immunotherapy for Early-stage Solid Tumors

早期实体瘤的瘤内免疫疗法

Hong, Wan Xing; Haebe, Sarah; Lee, Andrew S; Westphalen, C Benedikt; Norton, Jeffrey A; Jiang, Wen; Levy, Ronald

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

滤泡性淋巴瘤24个月内疾病进展与肿瘤内免疫浸润减少相关

Tobin, Joshua W D; Keane, Colm; Gunawardana, Jay; Mollee, Peter; Birch, Simone; Hoang, Thanh; Lee, Justina; Li, Li; Huang, Li; Murigneux, Valentine; Fink, J Lynn; Matigian, Nicholas; Vari, Frank; Francis, Santiyagu; Kridel, Robert; Weigert, Oliver; Haebe, Sarah; Jurinovic, Vindi; Klapper, Wolfram; Steidl, Christian; Sehn, Laurie H; Law, Soi-Cheng; Wykes, Michelle N; Gandhi, Maher K

It's a long way to the top (if you want to personalize immunotherapy)

要想实现个性化免疫疗法,还有很长的路要走。

Haebe, Sarah; Weigert, Oliver